Authors:
Elizabeth Yett, PharmD, BCACP, TTS
Jessica Wooster, PharmD, BCACP
Reviewers:
Austin Morgan, PharmD, BCACP
Stuart T Haines, PharmD, BCACP, BCPS
Citation:
Margolis KL, Bergdall AR, Crain AL, et al. Comparing Pharmacist-Led Telehealth Care and Clinic-Based Care for Uncontrolled High Blood Pressure: The Hyperlink 3 Pragmatic Cluster-Randomized Trial. Hypertension. 2022;79(12):2708-2720.
The Problem
Hypertension is one of the “big 3” cardiometabolic disease states, along with diabetes, dyslipidemia, and obesity, that are routinely managed by ambulatory care and community practitioners. Elevated blood pressure is the most common modifiable risk factor that contributes to morbidity and mortality in the United States. Moreover, there is irrefutable evidence that maintaining goal blood pressure decreases the risk of cardiovascular events. Despite patients’ and providers’ best efforts, blood pressure control is still suboptimal. The US Surgeon General’s Call to Action to Control Hypertension in 2020 advocated for team-based care as one of the top strategies to improve hypertension care.1
Excellent discussion. We offer a similar program at my institution. Patients are provided with a BP monitor, and comprehensive education upon enrollment. Pharmacists monitor and follow-patients via telehealth after the first clinic visit for patients with hypertension. The preliminary findings are promising for improvement in BP control.